V E Kelley

6.4k total citations · 1 hit paper
68 papers, 5.3k citations indexed

About

V E Kelley is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Rheumatology. According to data from OpenAlex, V E Kelley has authored 68 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Immunology, 13 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Rheumatology. Recurrent topics in V E Kelley's work include T-cell and B-cell Immunology (21 papers), Immune Cell Function and Interaction (16 papers) and Monoclonal and Polyclonal Antibodies Research (13 papers). V E Kelley is often cited by papers focused on T-cell and B-cell Immunology (21 papers), Immune Cell Function and Interaction (16 papers) and Monoclonal and Polyclonal Antibodies Research (13 papers). V E Kelley collaborates with scholars based in United States, Switzerland and Belgium. V E Kelley's co-authors include Mary A. Yui, Shozo Izui, J B Roths, Terry B. Strom, Rudolf P. Wüthrich, Stefan Endres, Tina S. Rogers, Charles A. Dinarello, Sheldon Wolff and Ernst J. Schaefer and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

V E Kelley

67 papers receiving 4.9k citations

Hit Papers

The Effect of Dietary Supplementation with n—3 Polyunsatu... 1989 2026 2001 2013 1989 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V E Kelley United States 30 2.2k 1.5k 904 832 831 68 5.3k
Niels Grunnet Denmark 40 1.1k 0.5× 353 0.2× 387 0.4× 662 0.8× 1.1k 1.3× 217 5.1k
J Bariéty France 45 1.6k 0.7× 185 0.1× 958 1.1× 924 1.1× 1.6k 1.9× 221 7.0k
Richard I. Rynes United States 20 576 0.3× 714 0.5× 765 0.8× 371 0.4× 313 0.4× 42 2.3k
Frederick C. de Beer United States 52 1.5k 0.7× 576 0.4× 425 0.5× 3.3k 3.9× 3.7k 4.5× 131 8.3k
Peter Vadas Canada 39 1.0k 0.5× 428 0.3× 550 0.6× 819 1.0× 2.2k 2.6× 138 5.7k
Giuseppe A. Andres United States 42 1.3k 0.6× 146 0.1× 616 0.7× 623 0.7× 886 1.1× 138 4.7k
Michael Torzewski Germany 34 1.7k 0.8× 359 0.2× 221 0.2× 1.1k 1.4× 1.1k 1.3× 63 4.7k
Knud Kragballe Denmark 53 5.2k 2.3× 441 0.3× 866 1.0× 321 0.4× 2.2k 2.6× 256 9.2k
Korbinian Brand Germany 42 2.3k 1.0× 254 0.2× 226 0.3× 1.1k 1.3× 2.1k 2.6× 112 7.5k
Lynell W. Klassen United States 39 1.2k 0.5× 275 0.2× 1.6k 1.7× 346 0.4× 704 0.8× 137 5.0k

Countries citing papers authored by V E Kelley

Since Specialization
Citations

This map shows the geographic impact of V E Kelley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V E Kelley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V E Kelley more than expected).

Fields of papers citing papers by V E Kelley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V E Kelley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V E Kelley. The network helps show where V E Kelley may publish in the future.

Co-authorship network of co-authors of V E Kelley

This figure shows the co-authorship network connecting the top 25 collaborators of V E Kelley. A scholar is included among the top collaborators of V E Kelley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V E Kelley. V E Kelley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jevnikar, Anthony M., Daniel C. Brennan, Gary G. Singer, et al.. (1991). Stimulated kidney tubular epithelial cells express membrane associated and secreted TNFα. Kidney International. 40(2). 203–211. 141 indexed citations
2.
Mackie, James, O. Pankewycz, Marcus Gomes Bastos, V E Kelley, & Terry B. Strom. (1990). DOSE-RELATED MECHANISMS OF IMMUNOSUPPRESSION MEDIATED BY MURINE ANTI-CD3 MONOCLONAL ANTIBODY IN PANCREATIC ISLET CELL TRANSPLANTATION AND DELAYED-TYPE HYPERSENSITIVITY. Transplantation. 49(6). 1150–1154. 9 indexed citations
3.
Pankewycz, O., et al.. (1989). INTERLEUKIN-2-DIPHTHERIA TOXIN FUSION PROTEIN PROLONGS MURINE ISLET CELL ENGRAFTMENT. Transplantation. 47(2). 318–321. 21 indexed citations
4.
Brennan, Daniel C., Mary A. Yui, Rudolf P. Wüthrich, & V E Kelley. (1989). Tumor necrosis factor and IL-1 in New Zealand Black/White mice. Enhanced gene expression and acceleration of renal injury.. The Journal of Immunology. 143(11). 3470–3475. 213 indexed citations
5.
Kelley, V E, et al.. (1989). ENHANCEMENT OF IMMUNOSUPPRESSION BY SUBSTITUTION OF FISH OIL FOR OLIVE OIL AS A VEHICLE FOR CYCLOSPORINE. Transplantation. 48(1). 98–101. 40 indexed citations
6.
Yui, Mary A., et al.. (1988). Increased tumor necrosis factor and IL-1 beta gene expression in the kidneys of mice with lupus nephritis.. The Journal of Immunology. 141(9). 3050–3054. 270 indexed citations
7.
Kelley, V E, Glen N. Gaulton, Masaya Hattori, et al.. (1988). Anti-interleukin 2 receptor antibody suppresses murine diabetic insulitis and lupus nephritis.. The Journal of Immunology. 140(1). 59–61. 105 indexed citations
8.
Rogers, Tina S., et al.. (1988). SELECTIVE ENHANCEMENT OF THROMBOXANE IN MACROPHAGES AND KIDNEYS IN CYCLOSPORINE-INDUCED NEPHROTOXICITY. Transplantation. 45(1). 153–156. 44 indexed citations
9.
10.
Elzinga, L W, V E Kelley, Donald C. Houghton, & William M. Bennett. (1987). Fish oil vehicle for cyclosporine lowers renal thromboxanes and reduces experimental nephrotoxicity.. PubMed. 19(1 Pt 2). 1403–6. 10 indexed citations
11.
Williams, John M., V E Kelley, Robert L. Kirkman, et al.. (1987). T Cell Activation Antigens: Therapeutic Implications. Immunological Investigations. 16(8). 687–723. 14 indexed citations
12.
Hinglais, N, Lucette Pelletier, M C Vial, et al.. (1986). Effect of prostaglandin E1 in brown Norway rats with mercury-induced autoimmune disease. Clinical Immunology and Immunopathology. 40(3). 401–409. 7 indexed citations
13.
Kirkman, Robert L., Leslie V. Barrett, Glen N. Gaulton, et al.. (1985). Administration of an anti-interleukin 2 receptor monoclonal antibody prolongs cardiac allograft survival in mice.. The Journal of Experimental Medicine. 162(1). 358–362. 147 indexed citations
14.
Rudofsky, Ulrich H., et al.. (1984). Differences in the occurrence of hypertension among (NZB X NZW)F1, MRL-lpr, and BXSB mice with lupus nephritis.. PubMed. 116(1). 107–14. 31 indexed citations
15.
Kelley, V E, et al.. (1983). Modification of expression of lpr by background genome. Federation Proceedings. 42(4). 4592. 9 indexed citations
16.
Weill, Bernard, et al.. (1983). Use of nuclear antigen-coated red cells in hemolytic plaque assays. Journal of Immunological Methods. 57(1-3). 327–340. 5 indexed citations
17.
Kelley, V E & J B Roths. (1982). Increase in macrophage Ia expression in autoimmune mice: role of the Ipr gene.. The Journal of Immunology. 129(3). 923–925. 70 indexed citations
18.
Kelley, V E, Alan Winkelstein, & Shozo Izui. (1979). Effect of prostaglandin E on immune complex nephritis in NZB/W mice.. PubMed. 41(6). 531–7. 60 indexed citations
19.
Kelley, V E & Tito Cavallo. (1977). Glomerular permeability. Ultrastructural studies in New Zealand black/white mice using polyanionic ferritin as a molecular probe.. PubMed. 37(3). 265–75. 21 indexed citations
20.
Kelley, V E & Tito Cavallo. (1976). An ultrastructural study of the glomerular slit diaphragm in New Zealand black/white mice.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 35(3). 213–20. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026